BFRI logo

BFRI Biofrontera Inc.

NASDAQ · Medical - Pharmaceuticals · Healthcare

$0.53
-0.04 (-7.02%)

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquarter…

Market Cap: $7.87Mwww.biofrontera-us.com

Price

No data yet.

Social Signal Score

56
5d
—
30d
63
4 mentions
—
60d
55
5 mentions
—
90d
51
6 mentions
—
news: 6

Analyst Ratings

1 analyst
Buyconsensus
Strong Buy 0Buy 1Hold 0Sell 0Strong Sell 0

Revenue

$9.07M+96.19%
$2.40M$7.30M$12.20M$17.10M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-1.39
$-1.39–$-1.39
1 analysts
FY2026
$-0.62
$-0.62–$-0.62
1 analysts
FY2027
$0.40
$0.40–$0.40
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Hermann Lübbert
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
89
Beta
0.96
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-7.74
www.biofrontera-us.com